Page 292 - EJMO-9-2
P. 292
Eurasian Journal of
Medicine and Oncology QGJSF multi-target mechanisms in osteoporosis
doi: 10.3390/ijms21030800 214-3p inhibits osteoblastic bone formation. Nat Commun.
2016;7:10872.
67. Hu F, Jiang C, Bu G, Fu Y, Yu Y. Silencing long noncoding
RNA colon cancer-associated transcript-1 upregulates doi: 10.1038/ncomms10872
microRNA-34a-5p to promote proliferation and 70. Ohnuma K, Kasagi S, Uto K, et al. MicroRNA-124 inhibits
differentiation of osteoblasts in osteoporosis. Cancer Gene TNF-α- and IL-6-induced osteoclastogenesis. Rheumatol
Ther. 2021;28(10-11):1150-1161.
Int. 2019;39(4):689-695.
doi: 10.1038/s41417-020-00264-7
doi: 10.1007/s00296-018-4218-7
68. John AA, Xie J, Yang YS, et al. AAV-mediated delivery of 71. Liu C, Cao Z, Bai Y, et al. LncRNA AK077216 promotes
osteoblast/osteoclast-regulating miRNAs for osteoporosis RANKL-induced osteoclastogenesis and bone resorption
therapy. Mol Ther Nucleic Acids. 2022;29:296-311.
via NFATc1 by inhibition of NIP45. J Cell Physiol.
doi: 10.1016/j.omtn.2022.07.008 2019;234(2):1606-1617.
69. Li D, Liu J, Guo B, et al. Osteoclast-derived exosomal miR- doi: 10.1002/jcp.27031
Volume 9 Issue 2 (2025) 284 doi: 10.36922/EJMO025150103

